Kapa Biosystems Discloses Customers for DNA Polymerase Platform | GenomeWeb

NEW YORK (GenomeWeb News) – Kapa Biosystems said today that several biotech companies and research centers are using its Kapa2G Fast HotStart DNA Polymerase platform for genomic resequencing and SNP detection studies.

The company said the Kapa2G has been adopted by Agencourt Bioscience, Ceres, Memorial Sloan Kettering Cancer Center, and the National Institutes of Health's Intramural Sequencing Center.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.